2161 — Jbm (Healthcare) Share Price
Last trade - 00:00- HK$833.81m
- HK$911.89m
- HK$520.32m
- 84
- 86
- 18
- 72
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.83 | ||
| Price to Tang. Book | 5.44 | ||
| Price to Free Cashflow | 6.41 | ||
| Price to Sales | 1.37 | ||
| EV to EBITDA | 5.1 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.54% | ||
| Return on Equity | 10.08% | ||
| Operating Margin | 22.9% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 307.51 | 381.54 | 397.16 | 406.14 | 520.32 | n/a | n/a | 14.51% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +23.92 | -10.19 | -9.52 | -37.78 | +72.64 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
JBM Healthcare Ltd is an investment holding company mainly engages in the marketing and distribution of proprietary Chinese medicines. The Company operates its business through three segments. The Proprietary Chinese Medicines segment mainly distributes over the counter (OTC) proprietary Chinese medicines and concentrated Chinese medicine granule (CCMG) products. The Consumer Healthcare Products segment primarily distributes proprietary medicines in the form of OTC. The Health and Wellness Products segment sales and distributes health and wellness products. The Company operates business in domestic and overseas markets such as Southeast Asia, Europe, and North America.
Directors
- Kwong Yip Sum NEC (58)
- Yat Wai Wong CEO (57)
- Man Yee Au COO (48)
- Ka Kin Wong VPR (47)
- Lin Wang DGM (55)
- Ka Wing Chu EDR (47)
- Kau Lap Lam OTH (34)
- Hoi Ki Leung OTH (38)
- Chui Yee Lo OTH (53)
- Kwok Chun Yeung NED (61)
- Chun Leung Yim NED (59)
- Kam Chiu Chan NID (72)
- Shut Lee Lau NID (52)
- Ting Lung Luk NID (59)
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- January 7th, 2020
- Public Since
- February 5th, 2021
- No. of Employees
- 258
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 833,810,000
- Address
- Unit 2303-07, 23/F, Tower 1, Millennium, KOWLOON
- Web
- https://www.jbmhealthcare.com.hk/
- Phone
- +852 null22672178
- Auditors
- KPMG
Upcoming Events for 2161
Similar to 2161
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 16:08 UTC, shares in Jbm (Healthcare) are trading at HK$1.00. This share price information is delayed by 15 minutes.
Shares in Jbm (Healthcare) last closed at HK$1.00 and the price had moved by -3.85% over the past 365 days. In terms of relative price strength the Jbm (Healthcare) share price has underperformed the FTSE Developed Asia Pacific Index by -8.28% over the past year.
There is no consensus recommendation for this security.
The Jbm (Healthcare) dividend yield is 5.95% based on the trailing twelve month period.
Last year, Jbm (Healthcare) paid a total dividend of HK$0.06, and it currently has a trailing dividend yield of 5.95%. We do not have any data on when Jbm (Healthcare) is to next pay dividends.
We do not have data on when Jbm (Healthcare) is to next pay dividends. The historic dividend yield on Jbm (Healthcare) shares is currently 5.95%.
To buy shares in Jbm (Healthcare) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$1.00, shares in Jbm (Healthcare) had a market capitalisation of HK$833.81m.
Here are the trading details for Jbm (Healthcare):
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2161
Based on an overall assessment of its quality, value and momentum Jbm (Healthcare) is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Jbm (Healthcare). Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -16.97%.
As of the last closing price of HK$1.00, shares in Jbm (Healthcare) were trading -0.59% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Jbm (Healthcare) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$1.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Jbm (Healthcare)'s management team is headed by:
- Kwong Yip Sum - NEC
- Yat Wai Wong - CEO
- Man Yee Au - COO
- Ka Kin Wong - VPR
- Lin Wang - DGM
- Ka Wing Chu - EDR
- Kau Lap Lam - OTH
- Hoi Ki Leung - OTH
- Chui Yee Lo - OTH
- Kwok Chun Yeung - NED
- Chun Leung Yim - NED
- Kam Chiu Chan - NID
- Shut Lee Lau - NID
- Ting Lung Luk - NID